BIOTECH ACQUISITION COMPANY Marketable Securities
BIOTECH ACQUISITION COMPANY had Marketable Securities of $231.29 million as of 2022-09-30, per its 10-Q filed 2022-11-22.
Discontinued › Balance Sheet › Assets
us-gaap:MarketableSecurities · last filed 2022-11-22
- 2022-09-30: Marketable Securities $231.29M.
- 2022-06-30: Marketable Securities $230.28M.
- 2022-03-31: Marketable Securities $230.04M.
- 2021-12-31: Marketable Securities $230.02M.
| Period end | Marketable Securities |
|---|---|
| 2022-09-30 | $231.29M 10-Q · filed 2022-11-22 |
| 2022-06-30 | $230.28M 10-Q · filed 2022-08-22 |
| 2022-03-31 | $230.04M 10-Q · filed 2022-05-16 |
| 2021-12-31 | $230.02M 10-Q · filed 2022-11-22 |